Aziyo Biologics/$ELUT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Aziyo Biologics
Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.
Ticker
$ELUT
Sector
Primary listing
Employees
51
Headquarters
Website
Aziyo Biologics Metrics
BasicAdvanced
$83M
-
-$0.58
-
-
Price and volume
Market cap
$83M
52-week high
$3.46
52-week low
$1.61
Average daily volume
26K
Financial strength
Current ratio
0.587
Quick ratio
0.307
Long term debt to equity
-51.072
Total debt to equity
-61.002
Interest coverage (TTM)
-5.94%
Profitability
EBITDA (TTM)
-19.128
Gross margin (TTM)
44.67%
Net profit margin (TTM)
-90.01%
Operating margin (TTM)
-95.38%
Effective tax rate (TTM)
-0.12%
Revenue per employee (TTM)
$460,000
Management effectiveness
Return on assets (TTM)
-37.27%
Return on equity (TTM)
40.15%
Valuation
Price to revenue (TTM)
3.155
Price to book
-2.02
Price to tangible book (TTM)
-1.74
Growth
Revenue change (TTM)
-5.22%
Earnings per share change (TTM)
-80.33%
3-year revenue growth (CAGR)
-11.14%
3-year earnings per share growth (CAGR)
-41.50%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Aziyo Biologics stock?
Aziyo Biologics (ELUT) has a market cap of $83M as of August 18, 2025.
What is the P/E ratio for Aziyo Biologics stock?
The price to earnings (P/E) ratio for Aziyo Biologics (ELUT) stock is 0 as of August 18, 2025.
Does Aziyo Biologics stock pay dividends?
No, Aziyo Biologics (ELUT) stock does not pay dividends to its shareholders as of August 18, 2025.
When is the next Aziyo Biologics dividend payment date?
Aziyo Biologics (ELUT) stock does not pay dividends to its shareholders.
What is the beta indicator for Aziyo Biologics?
Aziyo Biologics (ELUT) does not currently have a Beta indicator.